Advertisement

Topics

Muscular Dystrophy Association (MDA) Company Profile

19:17 EST 22nd November 2017 | BioPortfolio


News Articles [604 Associated News Articles listed on BioPortfolio]

Shortened telomeres linked to dysfunction in Duchenne muscular dystrophy, researchers find

A discovery about muscular dystrophy disorders has been made that suggests new possibilities for treatment. Researchers found that stem cells in the muscles of muscular dystrophy patients may, at an e...

MDA announces 13 new research grants to advance treatment for neuromuscular diseases

The Muscular Dystrophy Association today announced 13 new research and development grants totaling $3.5 million to accelerate the development of treatments for muscular dystrophy, ALS and related life...

Researchers find shortened telomeres linked to dysfunction in Duchenne muscular dystrophy

Researchers from the Perelman School of Medicine at the University of Pennsylvania have made a discovery about muscular dystrophy disorders that suggest new possibilities for treatment. In a study pub...

Study: Drug Candidate Demonstrates Efficacy in Duchenne Muscular Dystrophy

NewsBiophytis clinical stage drug-candidate sarconeos demonstrates efficacy in preclinical models of Duchenne muscular dystrophy. Duchenne muscular dystrophy is a new 'Orphan' indication for Sarconeos...

SLU researcher draws bulls eye around muscular dystrophy drug targets

(Saint Louis University) Scientist Francis M. Sverdrup, Ph.D., studies an inherited type of muscular dystrophy that typically begins with weakness in the face and shoulders before spreading to all ske...

Duchenne Muscular Dystrophy: The Race For The $1bn Opportunity

With three products now approved in Europe and/or the US for Duchenne Muscular Dystrophy, an FDA decision pending on PCT...   

FDA rejects muscular dystrophy drug, says it doesn't work

This Oct. 14, 2015, file photo, shows the U.S. Food & Drug Administration campus in Silver Spring, Md. On Wednesday, Oct. 25, 2017, the FDA rejected an experimental drug for a common type of muscu...

Researchers replicate FSH muscular dystrophy in mice

A new study published in the journal Nature Communications describes a breakthrough in research related to facioscapulohumeral muscular dystrophy (FSHD). The debilitating genetic disease - which has n...

PubMed Articles [1646 Associated PubMed Articles listed on BioPortfolio]

Parents' Reactions to the Diagnosis of Duchenne Muscular Dystrophy: Associations Between Resolution, Family Functioning, and Child Behavior Problems.

Duchenne muscular dystrophy (DMD) is the most frequent inherited form of muscular dystrophy during childhood. DMD is a severe and progressive disease. Children initially have no symptoms, but the diag...

Parents' Reactions to the Diagnosis of Duchenne Muscular Dystrophy: Associations Between Resolution, Family Functioning, and Child Behavior Problems.

Duchenne muscular dystrophy (DMD) is the most frequent inherited form of muscular dystrophy during childhood. DMD is a severe and progressive disease. Children initially have no symptoms, but the diag...

Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy.

Duchenne muscular dystrophy (DMD) and Spinal muscular atrophy (SMA) causes significant disability and progressive functional impairment. Readily available instruments that assess functionality, especi...

Longitudinal Community Walking Activity in Duchenne Muscular Dystrophy.

Natural history studies for Duchenne muscular dystrophy (DMD) have not included measures of community ambulation.

Energy expenditure, body composition, and prevalence of metabolic disorders in patients with Duchenne muscular dystrophy.

Duchenne muscular dystrophy (DMD) is a severe muscular disease characterized by progressive loss of functional muscle mass followed by changes in body composition.

Clinical Trials [1751 Associated Clinical Trials listed on BioPortfolio]

Ramipril Versus Carvedilol in Duchenne and Becker Patients

Data on preventive therapy in Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) affected individuals without cardiac involvement are very limited and currently lacking ...

Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy

The purpose of this study is to determine if ACE-031 is safe and well-tolerated in children with Duchenne Muscular Dystrophy (DMD) and to select the optimal doses of ACE-031 in terms of sa...

A Study of TAS-205 for Duchenne Muscular Dystrophy

The objective of this study is to evaluate the efficacy after 24-week repeated oral doses of TAS-205 in patients with Duchenne Muscular Dystrophy (DMD) in an exploratory manner.

Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy

This study will help to determine the effectiveness of glutamine and creatine as a possible therapy for DMD. Boys with DMD who are enrolled in this trial will be randomly chosen to receiv...

Cardiac Outcome Measures in Children With Muscular Dystrophy

The purpose of the research study is to evaluate different cardiac measures that are obtained by echocardiographic tests in patients with muscular dystrophy.

More Information about "Muscular Dystrophy Association (MDA)" on BioPortfolio

We have published hundreds of Muscular Dystrophy Association (MDA) news stories on BioPortfolio along with dozens of Muscular Dystrophy Association (MDA) Clinical Trials and PubMed Articles about Muscular Dystrophy Association (MDA) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Muscular Dystrophy Association (MDA) Companies in our database. You can also find out about relevant Muscular Dystrophy Association (MDA) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record